Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
NPJ Vaccines|April 15, 2025
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine developmentE Z Siegal, J M H Schoevers, J Terstappen, et al.
Allergy|July 1, 2008
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paperJ Bousquet, W Fokkens, P Burney, et al.
Allergy|November 20, 2010
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic reviewN G Papadopoulos, I Christodoulou, G Rohde, et al.
Allergy|October 5, 2010
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paperJean Bousquet, H J Schünemann, T Zuberbier, et al.
The European Respiratory Journal|June 14, 2014
Integrated care pathways for airway diseases (AIRWAYS-ICPs), , , et al.
The Journal of Allergy and Clinical Immunology|October 9, 2012
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needsJ Bousquet, H J Schünemann, B Samolinski, et al.
Allergy|July 7, 2015
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementationJ Bousquet, H J Schunemann, J Fonseca, et al.
The Journal of Nutrition, Health & Aging|December 22, 2016
Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHAJ Bousquet, M Bewick, A Cano, et al.
Clinical and Translational Allergy|February 28, 2017
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)J Bousquet, J Farrell, G Crooks, et al.
Clinical and Translational Allergy|August 2, 2016
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)J Bousquet, J Farrell, G Crooks, et al.
Pageof 26